Registration for Vaccine Against COVID-19 Starts at 4 PM
After the second wave of COVID-19, the government decided to open vaccination as the country had been struggling with the resources, such as the availability of beds, ventilators, and oxygen concentrators.
On Tuesday, India tallied over 3.6 lakh new COVID-19 cases and 3,293 deaths; this is the highest single-day count of infected patients till now. However, the government took a great initiative that overwhelmed the country.
The Indian government allows adults above 18 to register themselves for the vaccine against COVID-19 from 28th April 2021. The registration process for the vaccination is very simple; you just need to go to http://cowin.gov.in or use the UMANG App and Arogya Setu App to register yourself for the vaccination. Your appointment for the COVID-19 vaccination will be scheduled depending on the availability of vaccination centers on 1st May or later.
The center has opened Co-Win APIs for downloading certificates and searching vacancies of vaccination for the third-party applications – tweeted RS Sharma (CEO of National Health Authority). He also shared the link where API specs can be found. The link is apisetu.gov.in/public/marketplace/api/Cowin.
How to Register for the COVID-19 Vaccination
Go to the Cowin website and click on the register option. Now, you will have to enter the mobile number for generating an OTP. After that, verify yourself by entering the OTP you got on the number you entered.
Please enter your personal details now, such as name, photo ID, gender, age, etc. And then click on the “Register.” Now, go to the “Schedule” option, enter the pin code of your area, select your preferred vaccination center along with the date & time, and click on the confirmation button.
That’s all you need to do; you are ready for the vaccination now. Please keep in mind that your age should be 18 or above, and the registration portal will open today by 4 PM.
Which Vaccines Are Being Used?
India is currently using two vaccines – Covaxin manufactured by Bharat Biotech and Covishield manufactured by Serum Institute of India. All the vaccine manufacturers will supply 50 percent of the dosages to the central government and the rest to the state governments and in the open market.